The wireless polysomnography market size is projected to be worth US$ 197.7 million in 2023. The market is likely to surpass US$ 329.8 million by 2033 at a CAGR of 5.2% during the forecast period. The phases and cycles of sleep are monitored using polysomnography equipment. Modern polysomnography (PSG) equipment may remotely communicate data to medical professionals for processing.
In the upcoming years, the availability of both portable and stationary devices is predicted to drive market growth. Devices that are small and portable are becoming more popular. For market participants, the creation of software with precise and thorough analytical capabilities is anticipated to provide profitable development potential.
Other Drivers Propelling the Demand for Wireless Polysomnography include:
Challenges for Companies /Manufacturers in the Wireless Polysomnography Market:
Opportunities in the Wireless Polysomnography Industry:
Latest Trends in the Wireless Polysomnography Market:
| Attributes | Details |
|---|---|
| Wireless Polysomnography Market Size (2023) | US$ 197.7 million |
| Wireless Polysomnography Market Projected Size (2033) | US$ 329.8 million |
| Value CAGR (2023 to 2033) | 5.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2012 to 2022, the global wireless polysomnography market experienced a CAGR of 3.6%, reaching a market size of US$ 197.7 million in 2023.
From 2012 to 2022, the global wireless polysomnography industry witnessed steady growth due to the greater mobility and ease of use. Polysomnography was mostly performed in sleep labs using wired equipment. Wireless PSG systems were designed to provide a more convenient and comfortable option. Because of their greater mobility and ease of use, wireless PSG systems have grown in popularity. Adoption in sleep clinics and hospitals has increasing.
Wireless communication and sensor technology advancements have greatly expanded the possibilities of wireless PSG systems. As a result, data gathering, analysis, and patient comfort have all improved.
Future Forecast for Wireless Polysomnography Industry:
Looking ahead, the global wireless polysomnography industry is expected to rise at a CAGR of 5.2% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 329.8 million by 2033.
The wireless polysomnography industry is expected to continue its growth trajectory from 2023 to 2033, driven by increasing prevalence of sleep apnea. Sleep disorders including sleep apnea and insomnia are growing increasingly common as a result of causes such as lifestyle changes, stress, and ageing populations. This trend is projected to boost future demand for wireless PSG systems.
Home-based sleep monitoring is becoming more popular as a way to improve patient comfort and convenience while lowering healthcare expenses. Wireless PSG devices are ideal for this application because they allow patients to complete sleep studies in the comfort of their own homes.
| Country | The United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 105.7 million |
| CAGR % 2023 to End of Forecast (2033) | 4.7% |
The wireless polysomnography industry in the United States is expected to reach a market size of US$ 105.7 million by 2033, expanding at a CAGR of 4.7%. Wireless polysomnography is expected to see growth in the US market due to the increasing prevalence of sleep-related disorders. The America Sleep Association estimates that between 50 and 70 million individuals in the USA have sleep apnea in 2021. In the United States, sleep problems are fairly common, thus a proper diagnosis is also quite important. As a result, the country is adopting wireless polysomnography equipment for medical diagnostics.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 20.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.4% |
The wireless polysomnography industry in the United Kingdom is expected to reach a market value of US$ 20.1 million, expanding at a CAGR of 6.4% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing government initiatives and favorable policies. The government of the United Kingdom has taken, or is preparing to take, a number of actions to combat obstructive sleep apnea cycle. In section 3.10, the government lists sleep apnea as an adult impairment. Such patients receive additional advantages, from education to therapy, removing any financial strain. The above-mentioned regulations all increased the need for wireless polysomnography.
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 21.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.0% |
The wireless polysomnography industry in China is anticipated to reach a market size of US$ 21.1 million, moving at a CAGR of 6.0% during the forecast period. The wireless polysomnography industry in China is expected to grow prominently due to the increasing prevalence of sleep related disorders. Obstructive sleep apnea and other sleep disorders are quite prevalent in China. According to the paper A narrative review of obstructive sleep apnea in China: A sleeping giant in disease pathology, in Heart Mind 2022, 176 million Chinese citizens suffer from obstructive sleep apnea. This rising prevalence contributes to the market growth for wireless polysomnography in the country.
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 15.2 million |
| CAGR % 2023 to End of Forecast (2033) | 5.7% |
The wireless polysomnography industry in Japan is estimated to reach a market size of US$ 15.2 million by 2033, thriving at a CAGR of 5.7%. The market in Japan is predicted to grow because of the growing awareness and acceptance. There is an increasing need for efficient treatment alternatives, such as polysomnography in the country as more individuals are becoming aware of the health dangers linked to disorders that cause sleep disorder issues. The elderly population in Japan is another significant market driver. The chance of developing sleep apnea rises with age, increasing the need for polysomnography.
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 12.3 million |
| CAGR % 2023 to End of Forecast (2033) | 6.3% |
The wireless polysomnography industry in South Korea is expected to reach a market size of US$ 12.3 million, expanding at a CAGR of 6.3% during the forecast period. In South Korea, sleeplessness is more common than earlier. People who experience the symptoms of insomnia report a worsening of their quality of life in many areas and have a higher risk of developing other psychiatric illnesses. Thus, the rising incidence of insomnia is increasing people's knowledge of sleep problems, which is assisting the market's expansion.
Principal Consultant
The up-to 24 channel PSG systems is expected to dominate the wireless polysomnography industry with a CAGR of 4.4% from 2023 to 2033. Since there are more devices in the range of up to 24 channel PSG systems available than in the other product categories, this sector dominates the market for wireless polysomnography equipment.
The Ambulatory PSG segments are expected to dominate the wireless polysomnography industry with a CAGR of 5.6% from 2023 to 2033. This segment captures a significant market share in 2023.
Ambulatory PSG sleep tests are increasingly being used to diagnose sleep disorders. Ambulatory PSG allows to conduct of an overnight polysomnography assessment while the patient is still at home. These technologies provide sleep clinics with the flexibility of wireless and portable PSG systems by transporting sleep studies from the sleep clinic to the patient's home.
The Obstructive sleep apnea (OSA) segments is expected to dominate the wireless polysomnography industry with a CAGR of 4.7% from 2023 to 2033. As the occurrences of obstructive sleep apnea are increasing in comparison to the other sectors, this category is going to hold a considerable market share in 2023.
Polysomnography captures and classifies sleep phases, as well as the occurrence and duration of apneic and hypopneic episodes. It is useful for verifying OSA diagnosis and assessing OSA severity.
The sleep laboratories segment is expected to dominate the wireless polysomnography industry with a CAGR of 4.7% from 2023 to 2033. The increasing number of clinics sleep clinics or laboratories in the field of sleep medicine is a key factor due to which the sleep laboratories have been estimated to account for more than half of the share of the end user segment in the forecast period as well.
The wireless polysomnography sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
Key players focus on developing and introducing innovative products to address unmet needs in the market. They invest in research and development to improve existing formulations, delivery systems, and enhance the efficacy and safety of the products
Key players often form strategic partnerships and collaborations with other companies, research institutes, or healthcare organizations, these partnerships allow for knowledge sharing, joint research and development efforts, and access to complementary technologies or expertise.
Key players strive to expand their presence in different geographic regions to tap into new markets and reach a wider customer base. They may establish subsidiaries, distribution networks or strategic alliances in various countries to strengthen their market position.
Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Wireless Polysomnography Market:
The global wireless polysomnography industry is expected to hit a value of US$ 197.7 million by 2023.
The wireless polysomnography demand is set to expand by 5.2% during the assessment period.
The Up-to 24 Channel PSG Systems is projected to hold the dominant share of the market.
The market is predicted to exceed US$ 329.8 million by 2033.
The United States offers key opportunities for new entrants in the wireless polysomnography industry.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends and Supply Side Trends 1.3. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Product Features/ USPs 4.3. Technological Roadmap 4.4. Regulatory Landscape 4.5. PESTEL Analysis 4.6. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Life Expectancy Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Increasing Prevalence of Sleep Disorders 5.2.3. Favourable Government Regulations 5.2.4. Rising Demand for Home Sleep Testing 5.2.5. Technological Advancement in Wireless Technology 5.2.6. Key Market Players Strategic Partnerships and Collaborations 5.2.7. Growing Awareness and Education Initiatives 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2012 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 9.3.1. Up-to 12 Channel PSG Systems 9.3.2. Up-to 24 Channel PSG Systems 9.3.3. Up-to 32 Channel PSG Systems 9.3.4. Above 32 Channel PSG Systems 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Application, 2012 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 10.3.1. Ambulatory Polysomnography 10.3.2. In-laboratory Polysomnography 10.4. Market Attractiveness Analysis By Application 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Therapeutic Indication 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Therapeutic Indication, 2012 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Therapeutic Indication, 2023 to 2033 11.3.1. Obstructive Sleep Apnea 11.3.2. Narcolepsy 11.3.3. Chronic Insomnia 11.3.4. Others 11.4. Market Attractiveness Analysis By Therapeutic Indication 12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 12.3.1. Hospitals 12.3.2. Clinics 12.3.3. Sleep Laboratories 12.3.4. Home Care Settings 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Application 14.3.4. By Therapeutic Indication 14.3.5. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By Therapeutic Indication 14.4.5. By End User 14.5. Country Level Analysis & Forecast 14.5.1. USA Market Analysis 14.5.1.1. .Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Application 14.5.1.2.3. By Therapeutic Indication 14.5.1.2.4. By End User 14.5.2. Canada Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Application 14.5.2.2.3. By Therapeutic Indication 14.5.2.2.4. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Application 15.3.4. By Therapeutic Indication 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By Therapeutic Indication 15.4.5. By End User 15.5. Country Level Analysis & Forecast 15.5.1. Brazil Market Analysis 15.5.1.1. .Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Application 15.5.1.2.3. By Therapeutic Indication 15.5.1.2.4. By End User 15.5.2. Mexico Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Application 15.5.2.2.3. By Therapeutic Indication 15.5.2.2.4. By End User 15.5.3. Argentina Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Application 15.5.3.2.3. By Therapeutic Indication 15.5.3.2.4. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. France 16.3.1.3. Italy 16.3.1.4. UK 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Rest of Europe 16.3.2. By Product 16.3.3. By Application 16.3.4. By Therapeutic Indication 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By Therapeutic Indication 16.4.5. By End User 16.5. Country Level Analysis & Forecast 16.5.1. Germany Market Analysis 16.5.1.1. .Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Application 16.5.1.2.3. By Therapeutic Indication 16.5.1.2.4. By End User 16.5.2. France Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Application 16.5.2.2.3. By Therapeutic Indication 16.5.2.2.4. By End User 16.5.3. Italy Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Application 16.5.3.2.3. By Therapeutic Indication 16.5.3.2.4. By End User 16.5.4. UK Market Analysis 16.5.4.1. .Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product 16.5.4.2.2. By Application 16.5.4.2.3. By Therapeutic Indication 16.5.4.2.4. By End User 16.5.5. Spain Market Analysis 16.5.5.1. .Introduction 16.5.5.2. Market Analysis and Forecast by Market Taxonomy 16.5.5.2.1. By Product 16.5.5.2.2. By Application 16.5.5.2.3. By Therapeutic Indication 16.5.5.2.4. By End User 16.5.6. Russia Market Analysis 16.5.6.1. .Introduction 16.5.6.2. Market Analysis and Forecast by Market Taxonomy 16.5.6.2.1. By Product 16.5.6.2.2. By Application 16.5.6.2.3. By Therapeutic Indication 16.5.6.2.4. By End User 16.5.7. BENELUX Market Analysis 16.5.7.1. .Introduction 16.5.7.2. Market Analysis and Forecast by Market Taxonomy 16.5.7.2.1. By Product 16.5.7.2.2. By Application 16.5.7.2.3. By Therapeutic Indication 16.5.7.2.4. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Application 17.3.4. By Therapeutic Indication 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By Therapeutic Indication 17.4.5. By End User 17.5. Country Level Analysis & Forecast 17.5.1. India Market Analysis 17.5.1.1. .Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Application 17.5.1.2.3. By Therapeutic Indication 17.5.1.2.4. By End User 17.5.2. Thailand Market Analysis 17.5.2.1. .Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Application 17.5.2.2.3. By Therapeutic Indication 17.5.2.2.4. By End User 17.5.3. Indonesia Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Application 17.5.3.2.3. By Therapeutic Indication 17.5.3.2.4. By End User 17.5.4. Malaysia Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Product 17.5.4.2.2. By Application 17.5.4.2.3. By Therapeutic Indication 17.5.4.2.4. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Application 18.3.4. By Therapeutic Indication 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By Therapeutic Indication 18.4.5. By End User 18.5. Country Level Analysis & Forecast 18.5.1. China Market Analysis 18.5.1.1. .Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Application 18.5.1.2.3. By Therapeutic Indication 18.5.1.2.4. By End User 18.5.2. Japan Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Application 18.5.2.2.3. By Therapeutic Indication 18.5.2.2.4. By End User 18.5.3. South Korea Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By Application 18.5.3.2.3. By Therapeutic Indication 18.5.3.2.4. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Application 19.3.4. By Therapeutic Indication 19.3.5. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By Therapeutic Indication 19.4.5. By End User 19.5. Country Level Analysis & Forecast 19.5.1. Australia Market Analysis 19.5.1.1. .Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Application 19.5.1.2.3. By Therapeutic Indication 19.5.1.2.4. By End User 19.5.2. New Zealand Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Application 19.5.2.2.3. By Therapeutic Indication 19.5.2.2.4. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Türkiye 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Application 20.3.4. By Therapeutic Indication 20.3.5. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Application 20.4.4. By Therapeutic Indication 20.4.5. By End User 20.5. Country Level Analysis & Forecast 20.5.1. GCC Countries Market Analysis 20.5.1.1. .Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Product 20.5.1.2.2. By Application 20.5.1.2.3. By Therapeutic Indication 20.5.1.2.4. By End User 20.5.2. Türkiye Market Analysis 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Product 20.5.2.2.2. By Application 20.5.2.2.3. By Therapeutic Indication 20.5.2.2.4. By End User 20.5.3. Northern Africa Market Analysis 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Product 20.5.3.2.2. By Application 20.5.3.2.3. By Therapeutic Indication 20.5.3.2.4. By End User 20.5.4. South Africa Market Analysis 20.5.4.1. Introduction 20.5.4.2. Market Analysis and Forecast by Market Taxonomy 20.5.4.2.1. By Product 20.5.4.2.2. By Application 20.5.4.2.3. By Therapeutic Indication 20.5.4.2.4. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Branding and Promotional Strategies, By Key Players 22.3. Key Development Analysis 22.4. Competition Deep Dive 22.4.1. Nox Medical 22.4.1.1. Overview 22.4.1.2. Product Portfolio 22.4.1.3. Key Financials 22.4.1.4. Sales Footprint 22.4.1.5. SWOT Analysis 22.4.1.6. Strategy Overview 22.4.1.6.1. Marketing Strategy 22.4.1.6.2. Product Strategy 22.4.1.6.3. Channel Strategy 22.4.2. Onera Technologies B.V. 22.4.2.1. Overview 22.4.2.2. Product Portfolio 22.4.2.3. Key Financials 22.4.2.4. Sales Footprint 22.4.2.5. SWOT Analysis 22.4.2.6. Strategy Overview 22.4.2.6.1. Marketing Strategy 22.4.2.6.2. Product Strategy 22.4.2.6.3. Channel Strategy 22.4.3. SOMNOmedics GmbH 22.4.3.1. Overview 22.4.3.2. Product Portfolio 22.4.3.3. Key Financials 22.4.3.4. Sales Footprint 22.4.3.5. SWOT Analysis 22.4.3.6. Strategy Overview 22.4.3.6.1. Marketing Strategy 22.4.3.6.2. Product Strategy 22.4.3.6.3. Channel Strategy 22.4.4. Recorders & Medicare Systems P Ltd. 22.4.4.1. Overview 22.4.4.2. Product Portfolio 22.4.4.3. Key Financials 22.4.4.4. Sales Footprint 22.4.4.5. SWOT Analysis 22.4.4.6. Strategy Overview 22.4.4.6.1. Marketing Strategy 22.4.4.6.2. Product Strategy 22.4.4.6.3. Channel Strategy 22.4.5. VentMed Technology Medical Co. Ltd 22.4.5.1. Overview 22.4.5.2. Product Portfolio 22.4.5.3. Key Financials 22.4.5.4. Sales Footprint 22.4.5.5. SWOT Analysis 22.4.5.6. Strategy Overview 22.4.5.6.1. Marketing Strategy 22.4.5.6.2. Product Strategy 22.4.5.6.3. Channel Strategy 22.4.6. Koninklijke Philips N.V. 22.4.6.1. Overview 22.4.6.2. Product Portfolio 22.4.6.3. Key Financials 22.4.6.4. Sales Footprint 22.4.6.5. SWOT Analysis 22.4.6.6. Strategy Overview 22.4.6.6.1. Marketing Strategy 22.4.6.6.2. Product Strategy 22.4.6.6.3. Channel Strategy 22.4.7. Allengers Medical Systems Limited 22.4.7.1. Overview 22.4.7.2. Product Portfolio 22.4.7.3. Key Financials 22.4.7.4. Sales Footprint 22.4.7.5. SWOT Analysis 22.4.7.6. Strategy Overview 22.4.7.6.1. Marketing Strategy 22.4.7.6.2. Product Strategy 22.4.7.6.3. Channel Strategy 22.4.8. Natus Medical Incorporated 22.4.8.1. Overview 22.4.8.2. Product Portfolio 22.4.8.3. Key Financials 22.4.8.4. Sales Footprint 22.4.8.5. SWOT Analysis 22.4.8.6. Strategy Overview 22.4.8.6.1. Marketing Strategy 22.4.8.6.2. Product Strategy 22.4.8.6.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Wireless Polysomnography Market
